Evercore ISI Issues Positive Forecast for Agilent Technologies (NYSE:A) Stock Price

Key Points

• Evercore ISI raised its target price for Agilent Technologies from $128.00 to $140.00, indicating a potential upside of 0.73% from the company's previous close.
• The stock currently holds a consensus rating of "Hold" among analysts, with six rating it as a Buy and seven maintaining a Hold rating.
• Agilent Technologies reported $1.37 earnings per share for the last quarter, meeting analysts' expectations, and achieved a 10.1% revenue increase compared to the same quarter last year.

Agilent Technologies (NYSE:A - Get Free Report) had its target price boosted by research analysts at Evercore ISI from $128.00 to $140.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an "in-line" rating on the medical research company's stock. Evercore ISI's target price would indicate a potential upside of 0.73% from the company's previous close.

Several other research analysts also recently commented on A. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Friday. Robert W. Baird raised their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a research report on Thursday, August 28th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Agilent Technologies in a report on Saturday, September 27th. Wells Fargo & Company boosted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an "overweight" rating in a research report on Monday, September 15th. Finally, Barclays increased their price objective on Agilent Technologies from $125.00 to $150.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 2nd. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $143.17.

Agilent Technologies Stock Performance

NYSE:A traded down $2.62 on Tuesday, reaching $138.99. 458,133 shares of the company's stock were exchanged, compared to its average volume of 1,938,680. The stock has a fifty day simple moving average of $123.24 and a 200-day simple moving average of $116.49. The firm has a market cap of $39.40 billion, a price-to-earnings ratio of 32.63, a P/E/G ratio of 4.62 and a beta of 1.26. Agilent Technologies has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.67 billion. During the same quarter in the previous year, the firm posted $1.32 EPS. The business's revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, sell-side analysts predict that Agilent Technologies will post 5.58 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in A. Assenagon Asset Management S.A. grew its holdings in Agilent Technologies by 10.4% in the third quarter. Assenagon Asset Management S.A. now owns 38,029 shares of the medical research company's stock worth $4,881,000 after purchasing an additional 3,597 shares during the last quarter. Nilsine Partners LLC grew its stake in Agilent Technologies by 1.3% during the 3rd quarter. Nilsine Partners LLC now owns 9,525 shares of the medical research company's stock worth $1,223,000 after buying an additional 119 shares during the last quarter. Aaron Wealth Advisors LLC increased its position in Agilent Technologies by 322.2% during the 3rd quarter. Aaron Wealth Advisors LLC now owns 9,672 shares of the medical research company's stock valued at $1,241,000 after buying an additional 7,381 shares in the last quarter. GAMMA Investing LLC raised its stake in Agilent Technologies by 14.0% in the third quarter. GAMMA Investing LLC now owns 9,091 shares of the medical research company's stock valued at $1,167,000 after buying an additional 1,113 shares during the last quarter. Finally, Praxis Investment Management Inc. boosted its holdings in Agilent Technologies by 40.9% in the third quarter. Praxis Investment Management Inc. now owns 6,909 shares of the medical research company's stock worth $887,000 after acquiring an additional 2,004 shares in the last quarter. Hedge funds and other institutional investors own 87.41% of the company's stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.